Nisevokitug
Based on 1 Customer Validation
Nisevokitug (NIS-793) is a humanized IgG2λ monoclonal antibody and an inhibitor of the TGF-β signaling pathway. Nisevokitug blocks the binding of TGF-β to the membrane-bound TGF-βR1/TGF-βR2 receptors, inhibits both Smad-dependent and Smad-independent downstream cascade signaling, downregulates fibrosis-related genes, and reverses the TGF-β-mediated immunosuppressive microenvironment. Nisevokitug can be used in the research of diseases such as pancreatic ductal adenocarcinoma, colorectal cancer, myelofibrosis, and myelodysplastic syndrome.
For research use only. We do not sell to patients.
- Purity: 97.00%
- CAS No.: 2649854-92-0
- Molecular Weight:146.254 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG2 lambda
Human
|
TGF-βR2 |
Nisevokitug (NIS-793) binds competitively to soluble TGF-β ligands, reduces peripheral TGF-β protein levels in solid tumor models, inhibits TGF-β downstream Smad signaling in fibroblast and myeloid cell models and downregulates the expression of fibrosis-related genes, and also alleviates the TGF-β-mediated immunosuppressive microenvironment in tumor tissue models[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG2 lambda
ELISA, FACS, Functional assay
-
Flow cytometric analysis of 1X106 Raji cells with Nisevokitug (HY-P990009, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/50 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG2 lambda (HY-P991206, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 2649854-92-0
-
Appearance Liquid
-
Molecular Weight 146.254 kDa
-
Color Colorless to light yellow
-
SMILES
[Nisevokitug]
-
Synonyms
NIS-793
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (258 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Guo W, et al. Targeting the TGF-β signaling pathway: an updated patent review (2021-present). Expert opinion on therapeutic patents. 2024 Mar;34(3):99-126. [Content Brief]
[2]. Watrin T, et al. The tumor microenvironment in hairy cell leukemia (HCL) and splenic B cell lymphoma with prominent nucleoli (SBLPN). Leukemia & lymphoma. 2026 Jan;67(1):17-26. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)